verapamil hydrochloride
- Product NDC
- 71610-268
- 11-digit product format
- 716100268
- Labeler code
- 71610
- Product ID
- 71610-268_5dfba728-4417-4a75-b194-87feff97aa7b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA078906
- Marketing category
- ANDA
- Marketing start
- 2009-09-17
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 240 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V3888OEY5R | VERAPAMIL HYDROCHLORIDE | 152-11-4 | VERAPAMIL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-268-60 | 71610026860 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-268-60) | 2019-05-01 | No | No | Historical |